Evidence map›Paper›PMID 41111591›Full record

ArticleDiabetology international2025

Impact of isCGM on quality of life in overweight individuals with impaired glucose tolerance or mild diabetes: secondary analysis of a pilot randomized controlled study.

Seiji Nishikage, Yushi Hirota, Yasushi Nakagawa, Mei Nakatsuji, Shuichiro Saito, Kai Yoshimura, Mariko Ueda, Akane Yamamoto, Tomofumi Takayoshi, Atsuko Matsuoka and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Seiji NishikageDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Yushi HirotaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.ORCID 0000-0002-3035-4155
Yasushi NakagawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Mei NakatsujiDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Shuichiro SaitoDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Kai YoshimuraDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Mariko UedaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Akane YamamotoDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Tomofumi TakayoshiDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Atsuko MatsuokaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Michiko TakahashiDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Akihiko TakedaDepartment of Diabetes and Metabolism, Shinko Memorial Hospital, 1-4-47 Wakihama-cho, Chuo-ku, Kobe, 651-0072 Japan.
Kazuki YokotaYokota Medical Clinic, 1-6-1 Ooakashi-cho, Akashi, 673-0891 Japan.
Tomoaki NakamuraDepartment of Diabetes and Endocrinology, Akashi Medical Center, Aijinkai Social Medical Corporation, 743-33 Yagi, Ookubo-cho, Akashi, Japan.
Kazuhiko SakaguchiDivision of Community Medicine and Medical Education, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Wataru OgawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The impact of intermittently scanned continuous glucose monitoring (isCGM) on quality of life (QoL) for overweight individuals with impaired glucose tolerance (IGT) or mild type 2 diabetes (HbA1c ≤ 7.0%) remains unclear. Methods: In this secondary analysis of our pilot weight-loss RCT, 40 overweight individuals (BMI, ≥ 25 kg/m Results: After exclusion of participants with missing data or who withdrew consent, 17 individuals in the isCGM group (median [interquartile range] age, 51.0 [47.0-62.5] years; BMI, 35.0 [32.2-39.0] kg/m Conclusion: isCGM did not improve QoL scores relative to the control group for overweight individuals with IGT or mild diabetes. Within-group analysis suggested that isCGM improved mental QoL but lowered perceived social QoL. Tailored support addressing psychological and social needs may maximise isCGM benefits. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-025-00838-6.

Indexed as

Glycemic variabilityIntermittently scanned continuous glucose monitoring (isCGM)OverweightQuality of lifeRandomized controlled trialSelf-monitoring

Identifiers

PMID41111591
PMCPMC12532515

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.